MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sim1 who wrote (1667)	3/22/2006 1:18:04 PM
From: tuck	of 1826

Aside from the Aquavan news, I'd say the bigger driver if the recent share price recovery is Morningstar calling this an undervalued stock based on a screen: finance.messages.yahoo.com Hard to say how wide MOGN's "moat" is, and one wonders if Tran understands MOGN's issues, but hey, like the YMB poster, I'll take it, too. My last batch of sold calls expired very worthless, and I got to keep $1 per share. Now the rebound, three days after expiration, is a perfect scenario for the covered call writing strategy . . . I get to write another batch this soon at the same price, perhaps? Yeah, I'll take that . . . Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next